Saint Luke's Marion Bloch Neuroscience Institute Announces Fourth Annual Advances in Neuroscience Symposium

Share Article

Conference will focus on advances in diagnosis and treatment of neurological disorders.

Stroke and Cerebrovascular Conference

There have been significant advances in the diagnosis and treatment of many neurological diseases. This program will emphasize the evidence-based strategy for current treatment and cutting-edge research.

Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI), one of the region’s premier neuroscience programs, in conjunction with the Institute for International Medicine (INMED) and Saint Luke’s Hospital of Kansas City will present its Fourth Annual Advances in Neuroscience Symposium on Friday, Sept. 23, 2016 at the InterContinental Kansas City at the Plaza.

The program will focus on diagnosis and treatment of a broad range of neurologic disorders, featuring presentations by SLMBNI invited faculty members. Special guest presenters include internationally renowned neuroscientists Neeraj Kumar, M.D., Rachelle S. Doody, M.D., and Michael A. Williams, M.D.

“Saint Luke’s is committed to providing the best evidence-based treatment for our patients. In recent years there have been significant advances in the diagnosis and treatment of many neurological diseases,” said Stanley P. Fisher, M.D., co-director of the Neuroscience Institute. “This program will emphasize the evidence-based strategy for the current treatment and cutting-edge research in novel therapeutics, as well as advances in medical and surgical approaches to a variety of neurological disorders.”

Presenters will present on a variety of topics, including sessions on:

  • The role of imaging in the diagnosis of Parkinson’s disease
  • The role of gender in approach to patients with Multiple Sclerosis
  • The role of copper in neurological diseases
  • Advances in prevention and treatment of Alzheimer’s disease
  • Advances in diagnosis and treatment of idiopathic normal pressure hydrocephalus
  • Neuromodulation in neurosurgery
  • Novel treatment strategies for glioblastoma
  • Perils and pitfalls of epilepsy management
  • Advances in Cochlear implants

The conference has been planned and implemented in accordance with the Essential Areas and Policies of the Missouri State Medical Association through the joint providership of INMED and Saint Luke’s Hospital of Kansas City. Continuing education credits will be offered to physicians, physician assistants, advanced nurse practitioners and other healthcare professionals with an interest in neurology who attend the event. For more information and to register visit

About Saint Luke’s Marion Bloch Neuroscience Institute
Saint Luke’s Marion Bloch Neuroscience Institute is a comprehensive center for neuroscience research, education, and evidence-based medicine, that combines faculty in neurology, neurosurgery, interventional neuroradiology, neurotology, psychiatry, and physical medicine and rehabilitation. Together SLMBNI faculty provide patient-centered leading-edge care to thousands of patients from all over the country each year. As a member of Saint Luke’s Health System, SLMBNI is a global leader in utilizing both drug and mechanical interventions to reverse the permanent and debilitating effects of ischemic stroke. Its legacy of innovation began in 1993 when doctors performed one of the world’s first intra-arterial stroke reversal procedures. Since then, Saint Luke’s specialists have continued to pioneer new stroke treatments and reverse strokes in thousands of patients through its network of stroke centers. Located in Kansas City, Missouri, SLMBNI brings together a team of highly specialized neuroscientists to provide comprehensive treatment for the most complex neurological diseases, including stroke, epilepsy, brain tumors, Parkinson’s and Alzheimer’s diseases, multiple sclerosis, headaches and facial pain, as well as aneurysms and intracerebral hemorrhages. The Institute’s multispecialty team provides the latest in minimally invasive spinal surgical techniques for the treatment of acute and chronic back pain. SLMBNI strives to be a national leader in neurological treatment and care by advancing clinical research and evidence-based clinical practice.

Saint Luke’s Health System
Saint Luke’s Health System consists of 10 area hospitals and several primary and specialty care practices, and provides a range of inpatient, outpatient, and home care services. Founded as a faith-based, not-for-profit organization, our mission includes a commitment to the highest levels of excellence in health care and the advancement of medical research and education. The health system is an aligned organization in which the physicians and hospitals assume responsibility for enhancing the physical, mental, and spiritual health of people in the Kansas City metropolitan area and the surrounding region.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Manuel
Saint Luke's Health System
+1 (816) 502-8533
Email >